Crescita Therapeutics Inc.
CRRTF
$0.2371
-$0.1155-32.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.55% | -36.50% | -303.07% | -463.97% | -321.15% |
| Total Depreciation and Amortization | -14.83% | -10.64% | -8.97% | -3.70% | 0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.57% | -74.18% | 58.27% | -21.37% | 47.62% |
| Change in Net Operating Assets | 387.27% | 112.05% | 333.18% | 195.50% | 127.89% |
| Cash from Operations | 451.92% | 28.42% | 722.22% | 64.50% | -31.98% |
| Capital Expenditure | -1,505.20% | -1,458.31% | -4,338.36% | -6,788.29% | 31.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,446.89% | -1,400.00% | -1,619.50% | -1,265.36% | 47.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.67% | -8.09% | -7.71% | -8.95% | 69.80% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | 216.67% |
| Repurchase of Common Stock | 39.49% | 18.58% | -26.92% | -105.95% | -33.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | 0.00% | 0.00% | 0.00% |
| Cash from Financing | 17.21% | -8.40% | -16.95% | -38.87% | 50.36% |
| Foreign Exchange rate Adjustments | 369.09% | 396.12% | -361.02% | -56.31% | -113.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.48% | -111.22% | -120.78% | -365.67% | 51.30% |